Vascular Endothelial (VE)-cadherin-mediated adherens junctions involvement in cardiovascular progenitor cell specification

被引:3
作者
Maltabe, Violetta
Kouklis, Panos [1 ]
机构
[1] Univ Ioannina, Dept Med, Lab Biol, GR-45110 Ioannina, Greece
关键词
  adherens junctions; cardiovascular progenitors; VE-cadherin; VE-CADHERIN; EXPRESSION; HEART; GENE; MOUSE; MECHANOTRANSDUCTION; MORPHOGENESIS; PERMEABILITY; MECHANISMS; MOLECULES;
D O I
10.1387/ijdb.210167pk
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vascular Endothelial cadherin, a type II classical cadherin, is the major cadherin molecule participating in homotypic cell-cell adhesion structures between endothelial cells. It associates with cytoplasmic and membrane cytoskeletal elements to form endothelial adherens junctions (AJs), pivotal in regulating endothelial barrier function in the adult. VE-cadherin-mediated AJs are also involved in signaling via direct or indirect associations with receptors. The generation of mutant animals, especially mice and zebrafish, revealed many details concerning the role of VE-cadherin-mediated AJs in cardiovascular development. In general, VE-cadherin knockout (KO) in mice is embryonic lethal due to severe cardiovascular defects, and major signaling pathways as well as vascular formation cues were discovered in developing endothelium. However, there is little information regarding AJs formation and their components in cardiovascular progenitors. We have characterized in detail the activation pattern of mouse VE-cadherin promoter (Pvec) in a mouse embryonic stem cells (ESCs) differentiation system in vitro. Surprisingly, we found that it is activated transiently in cardiac progenitors that belong to the second heart field. Based on Pvec activation, we isolated this population in vitro and found that it can self-renew by induction of the Wnt/beta-catenin pathway. Next, we successfully established cell culture conditions that allowed self-renewal of this population that consists of endothelial and cardiac progenitors. Transplantation in rat hearts showed that they can survive and differentiate to cardiomyocytes and endothelial cells. Although further characterization is needed, these cells can be used in cell-based therapies as well as in drug screening.
引用
收藏
页码:77 / 83
页数:7
相关论文
共 45 条
  • [41] The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma
    Polena, Helena
    Creuzet, Julie
    Dufies, Maeva
    Sidibe, Adama
    Khalil-Mgharbel, Abir
    Salomon, Aude
    Deroux, Alban
    Quesada, Jean-Louis
    Roelants, Caroline
    Filhol, Odile
    Cochet, Claude
    Blanc, Ellen
    Ferlay-Segura, Celine
    Borchiellini, Delphine
    Ferrero, Jean-Marc
    Escudier, Bernard
    Negrier, Sylvie
    Pages, Gilles
    Vilgrain, Isabelle
    BRITISH JOURNAL OF CANCER, 2018, 118 (09) : 1179 - 1188
  • [42] Chlamydia pneumoniae infection promotes monocyte transendothelial migration by increasing vascular endothelial cell permeability via the tyrosine phosphorylation of VE-cadherin
    Liu, Jingya
    Miao, Guolin
    Wang, Beibei
    Zheng, Ningbo
    Ma, Lu
    Chen, Xiaoyu
    Wang, Guangyan
    Zhao, Xi
    Zhang, Lijun
    Zhang, Lijun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (02) : 742 - 748
  • [43] Cyclic AMP Phosphodiesterase 4D (PDE4D) Tethers EPAC1 in a Vascular Endothelial Cadherin (VE-Cad)-based Signaling Complex and Controls cAMP-mediated Vascular Permeability
    Rampersad, Sarah N.
    Ovens, Jeffrey D.
    Huston, Elaine
    Umana, M. Bibiana
    Wilson, Lindsay S.
    Netherton, Stuart J.
    Lynch, Martin J.
    Baillie, George S.
    Houslay, Miles D.
    Maurice, Donald H.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (44) : 33614 - 33622
  • [44] Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: Evidence for disruption of vascular integrity via VE-cadherin down-regulation
    Friedl, J
    Turner, E
    Alexander, HR
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (03) : 611 - 616
  • [45] Loxenatide attenuates ROS-mediated vascular endothelial progenitor cell damage and mitochondrial dysfunction via SIRT3/Foxo3 signaling pathway
    Yuan, Junfang
    Wang, Yuzhong
    Wang, Defeng
    Yan, Han
    Wang, Ning
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2023, 37 (11)